A double-blind, placebo-controlled trial of topiramate for pathological gambling
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Pathological gambling (PG) is an impulse control disorder characterized by recurrent gambling thoughts and behaviours that impair social functioning. Earlier studies suggested that topiramate may be effective in treating some impulse control disorders. We conducted the first randomized, controlled trial of topiramate in PG. METHODS: PG patients were randomized to topiramate (N = 20) or placebo (N = 22) in this 14-week, double-blind, placebo-controlled, parallel-group trial. The primary outcome measure was change in the obsessions subscale of the Yale-Brown Obsessive-Compulsive Scale Modified for Pathological Gambling. RESULTS: Mixed regression models (time [weeks] × treatment) revealed no significant treatment effect of topiramate on the primary or secondary outcome measures. The most statistically robust findings involved reducing the Barratt Impulsiveness Scale (BIS) total score and Motor and Non-Planning subscale scores, for which topiramate outperformed placebo at merely a trend level (P < 0.1). CONCLUSIONS: The observed trend in BIS score reductions may warrant further investigation to study whether topiramate reduces clinically important impulsivity in PG. Treatment studies with larger samples and less stringent exclusion criteria are needed to produce results that can be generalized to pathological gamblers in the community.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744 · cited 1×
“…with the exception of attending Gamblers Anonymous; commencement of formal psychotherapy within the past 3 months; a score of 15 on the Young Mania Rating Scale (YMRS; (Young et al. 1978)); or, a score of 24 on the Montgomery – Asberg Depression Rating Scale (MADRS; Montgomery and Asberg 1979).”
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.9.1184 · Cited by 2,948
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799
Evenden, J. L. (1999) · Psychopharmacology · doi:10.1007/pl00005481 · Cited by 2,044
Petry, N. M., Stinson, F. S., & Grant, B. F. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0504 · Cited by 1,245 · cited 1×
“Pathological gambling (PG) has a prevalence of about 1%, and co-morbid psychiatric conditions are common (Petry et al. 2005; Cunningham-Williams et al. 2005, 2007; Kessler et al. 2008).”
BackgroundAddiction, a disease of compulsion and drive: involvement of the orbitofrontal cortex
Volkow, N. D. (2000) · Cerebral Cortex · doi:10.1093/cercor/10.3.318 · Cited by 1,240
DSM-IV pathological gambling in the National Comorbidity Survey Replication
Kessler, R. C., Hwang, I., LaBrie, R., Petukhova, M., Sampson, N. A., Winters, K. C., & Shaffer, H. J. (2008) · Psychological Medicine · doi:10.1017/s0033291708002900 · Cited by 928 · cited 1×
“Pathological gambling (PG) has a prevalence of about 1%, and co-morbid psychiatric conditions are common (Petry et al. 2005; Cunningham-Williams et al. 2005, 2007; Kessler et al. 2008).”
BackgroundProbing compulsive and impulsive behaviors, from animal models to endophenotypes: A narrative review
Fineberg, N. A., Potenza, M. N., Chamberlain, S. R., Berlin, H. A., Menzies, L., Bechara, A., Sahakian, B. J., Robbins, T. W., Bullmore, E. T., & Hollander, E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.185 · Cited by 654
Self-citationTopiramate for Treating Alcohol Dependence<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Johnson, B. A. (2007) · JAMA · doi:10.1001/jama.298.14.1641 · Cited by 542
Cited by
Gambling Disorder and Other Behavioral Addictions: Recognition and Treatment
Yau, Y. H. C., & Potenza, M. N. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000051 · Cited by 267
Self-citationPhenomenology and treatment of behavioural addictions
Grant, J. E., Schreiber, L. R., & Odlaug, B. L. (2013) · The Canadian Journal of Psychiatry · doi:10.1177/070674371305800502 · Cited by 82
Nourredine, M., Jurek, L., Angerville, B., Longuet, Y., de Ternay, J., Derveaux, A., & Rolland, B. (2021) · CNS Drugs · doi:10.1007/s40263-020-00780-y · Cited by 26
“In one double-blind RCT of topiramate against placebo [67], topiramate was associated with a significant reduction in the impulsivity score on the BIS-11, with an end study score of 68.”
Background
Metadata
- Authors
- Berlin, H. A., Braun, A., Simeon, D., Koran, L. M., Potenza, M. N., McElroy, S. L., Fong, T., Pallanti, S., & Hollander, E.
- Venue
- The World Journal of Biological Psychiatry
- Publisher
- Informa UK Limited
- Published
- 2011-04-12
- Volume
- 14
- Issue
- 2
- Pages
- 121-128
- ISSN
- 1562-2975 (ISSN-L)
- 1814-1412
- OpenAlex
- W1986888566
- Cited by
- 110
- References
- 15
- FWCI
- 5.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A double-blind, placebo-controlled trial of topiramate for pathological gambling. https://app.cochat.ai/papers/10.3109/15622975.2011.560964
- The paper
- Berlin, H. A., Braun, A., Simeon, D., Koran, L. M., Potenza, M. N., McElroy, S. L., Fong, T., Pallanti, S., & Hollander, E. (2013). A double-blind, placebo-controlled trial of topiramate for pathological gambling. The World Journal of Biological Psychiatry. https://doi.org/10.3109/15622975.2011.560964
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.